Thermostable polymerase inhibitor compositions and methods
AssigneeCepheid
InventorsSergey G. Lokhov, Alexander A. Gall, Vera Baraznenok, Ekaterina V. Viazovkina, Irina Shishkina, David H. Persing
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to aptamers for temperature-dependent reversible inhibition of thermostable polymerase activity in order to improve sensitivity and specificity of various reactions and assays involving hot start polynucleotide synthesis. Methods for use of the aptamers and related compositions and kits are also provided.
Claims51
An aptamer comprising in a 5′ to 3′ direction:
- a first sequence comprising SEQ ID NO:1 or a variant thereof or SEQ ID NO:2 or a variant thereof,
- a second sequence comprising SEQ ID NO:3 or a variant thereof,
- a third sequence comprising SEQ ID NO:1 or a variant thereof or SEQ ID NO:2 or a variant thereof,
- and a fourth sequence comprising SEQ ID NO:3 or a variant thereof,
- wherein each of the first and third sequences are 14-18 nucleotides in length, are equal in length to each other, and are 100% complementary to each other along their entire length;
- and
- wherein the second and fourth sequences are 12 nucleotides in length and are identical to each other.
The aptamer of any one of the preceding claims, wherein the first and third sequences are hybridized to each other along the entire length of each of the first and third sequences.
An aptamer comprising an oligonucleotide comprising in a 5′ to 3′ direction:
- a first polynucleotide sequence comprising SEQ ID NO:4 or a variant thereof or SEQ ID NO:5 or a variant thereof,
- a second polynucleotide sequence comprising SEQ ID NO:3 or a variant thereof, and
- a third polynucleotide sequence comprising SEQ ID NO:5 or a variant thereof or SEQ ID NO:4 or a variant thereof, and
- a fourth polynucleotide sequence comprising SEQ ID NO:3 or a variant thereof,
- wherein each of the second and fourth sequences are 14-20 nucleotides in length, are equal in length, and are complementary to each other along their entire length;
- and wherein the aptamer comprises a 5′ end and a 3′ end.
An aptamer comprising a sequence selected from the group consisting of SEQ ID NO:82-105.
The aptamer of any one of the preceding claims, wherein the aptamer does not inhibit reverse transcriptase activity.
Dependencies are inferred from the claim text.